Scipher Medicine and Maxymune Therapeutics Partner to Advance AI-Driven Target Discovery in Immunology

Scipher Medicine, a pioneer in network-based and AI-driven precision immunology,  announced a strategic collaboration with Maxymune Therapeutics, a ...

September 11, 2025 | Thursday | News
Cytiva Joins Forces with WhiteLab Genomics to Shorten AAV Development Timelines

Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timeline ...

September 11, 2025 | Thursday | News
Trethera Completes Enrollment in Phase 1 Trial of TRE-515 for Advanced Solid Tumors

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

September 11, 2025 | Thursday | News
Greenwich LifeSciences Secures FDA Fast Track Designation for GLSI-100 in Breast Cancer

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-0...

September 11, 2025 | Thursday | News
Sapio Sciences and Ultima Genomics Forge Strategic Partnership to Streamline Multi-Omics Research

Sapio Sciences, the science-awareTM lab informatics platform,  announced a strategic partnership with Ultima Genomics. The collaboration will make m...

September 10, 2025 | Wednesday | News
Cascade Bio Secures $6M to Power Cell-Free Biomanufacturing Revolution

Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturi...

September 10, 2025 | Wednesday | News
Promega Partners with Watchmaker Genomics to Advance Reverse Transcriptase Technology

Partnership delivers advanced reverse transcriptase technology to enhance sensitivity, robustness and reproducibility of molecular analysis in clinical, ap...

September 10, 2025 | Wednesday | News
Booking Health Expands Access to Dendritic Cell Immunotherapy for Recurrent Glioblastoma as New Clinical Data Confirm Survival Gains

Booking Health, a global medical travel platform, announced the expansion of patient access to dendritic cell immunotherapy for recurrent glioblastoma, f...

September 10, 2025 | Wednesday | News
Enzene Inaugurates First U.S. Biomanufacturing Facility with Governor Phil Murphy in New Jersey

  Governor Phil Murphy officially inaugurated the state-of-the-art biomanufacturing facility of Enzene, a leading global continuously innovative deve...

September 10, 2025 | Wednesday | News
Samsung Biologics Secures Landmark W1.8 Trillion Manufacturing Agreement with US Partner

  Samsung Biologics, South Korea’s preeminent contract development and manufacturing organisation (CDMO), has entered into a momentous W1.8 tri...

September 10, 2025 | Wednesday | News
Tolerance Bio and ZipCode Bio Forge Strategic Collaboration to Develop Targeted RNA-Based Thymus Therapeutics

Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, and manipulating the functi...

September 09, 2025 | Tuesday | News
Corner Therapeutics Unveils Breakthrough Hyperactivator Technology Showing Potential for a Universal Influenza Vaccine and Cancer Immunotherapy

Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, published research in mB...

September 09, 2025 | Tuesday | Reports
NurExone Biologic Secures US Patent Allowance for Proprietary Exosome Production Process Strengthening Global Market Position

NurExone Biologic Inc. , a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the United S...

September 09, 2025 | Tuesday | News
23andMe Research Institute, TWP, and Lifebit Launch Open-Source Data Platform for Lung Cancer Genetics Study

23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the...

September 08, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close